Showing results (111-120 of 168) with videos related to

Sort By:
Pageof 17
Blood|November 1, 1981
Lysozyme enhances monocyte-mediated tumoricidal activity: a potential amplifying mechanism of tumor killingP LeMarbre, J J Rinehart, N E Kay, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|November 1, 1991
Hemin: a possible physiological mediator of low density lipoprotein oxidation and endothelial injuryG Balla, H S Jacob, J W Eaton, et al.
American Heart Journal|September 1, 1990
Evidence for a role of platelet activating factor in the pathogenesis of irreversible but not reversible myocardial injury after reperfusion in dogsM Maruyama, N E Farber, G M Vercellotti, et al.
The Journal of Clinical Investigation|May 1, 1978
Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes. An in vitro model of immune vascular damageT Sacks, C F Moldow, P R Craddock, et al.
The New England Journal of Medicine|April 7, 1977
Complement and leukocyte-mediated pulmonary dysfunction in hemodialysisP R Craddock, J Fehr, K L Brigham, et al.
The Journal of Clinical Investigation|May 1, 1977
Hemodialysis leukopenia. Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranesP R Craddock, J Fehr, A P Dalmasso, et al.
Blood|December 1, 1981
Abnormal erythrocyte calcium homeostasis in oxidant-induced hemolytic diseaseO Shalev, M N Leida, R P Hebbel, et al.
Blood|May 29, 2000
Ferriporphyrins and endothelium: a 2-edged sword-promotion of oxidation and induction of cytoprotectantsJ Balla, G Balla, V Jeney, et al.
The Journal of Clinical Investigation|July 1, 1977
Complement (C5-a)-induced granulocyte aggregation in vitro. A possible mechanism of complement-mediated leukostasis and leukopeniaP R Craddock, D Hammerschmidt, J G White, et al.
Blood|November 1, 1983
Inflamed fibronectin: an altered fibronectin enhances neutrophil adhesionG M Vercellotti, J McCarthy, L T Furcht, et al.
Pageof 17